Introduction 17 de febrero de 2025
El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.
- House Minnesota House of Representatives House Members and Staff House Members Leadership Staff Employment Who Represents Me? Committees Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Minutes Committee Deadlines Offices Chief Clerk Fiscal Analysis House Research Public Information Sergeant-at-Arms Caucuses - DFL/GOP Other Information House Journal House Rules Joint Rules Educational Programs Pronunciation Guide Address Spreadsheet
- Senate Minnesota Senate Senators and Staff Senators Leadership Staff Employment Who Represents Me? Committees Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Committee Deadlines Offices Secretary of the Senate Senate Counsel, Research & Fiscal Analysis Caucuses - DFL/GOP Other Information Senate Journal Senate Rules Joint Rules Educational Programs Address Labels Subscriptions
- Joint Joint Department, Offices, and Commissions Joint Legislative Offices Legislative Budget Office Legislative Coordinating Commission (LCC) Legislative Reference Library Office of the Legislative Auditor Office of the Revisor of Statutes Commissions Legislative-Citizen Commission on MN Resources Legislative Commission on Pensions & Retirement Lessard-Sams Outdoor Heritage Council More... More Information Joint Offices Directory Joint Offices Staff Accessibility Legacy Amendment
- Schedules Schedules, Calendars, and Legislative Business House House Schedules Order of Business Calendar for the Day Supplemental Calendar for the Day Fiscal Calendar Senate Senate Schedules Order of Business Senate Calendar General Orders of the Day Joint Combined Upcoming Meetings Broadcast TV Schedule Committee Deadlines
- Committees Legislative Committees House Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Minutes Senate Committee List Committee Roster Upcoming Meetings Standing Committee Schedule Joint Joint Committees & Task Forces Committee Deadlines Bills In Conference Committee Side by Side Comparisons
- Bills Bills House Bill Search & Status (House) Bill Introductions Bill Summaries Act Summaries Fiscal Tracking Sheets Senate Bill Search & Status (Senate) Bill Introductions Bill Summaries Act Summaries Fiscal Tracking Sheets Joint Bill Search & Status MyBills Side by Side Comparisons Bills In Conference Committee Vetoes Current Session Laws
- Law Statutes, Laws, and Rules Statutes Keyword Search Current Statutes Statutes by Topic (Index) Statutes Archive Session Laws Keyword Search Current Session Laws Session Laws by Topic (Index) Session Laws Archive Session Laws Changed (Table 1) Statutes Changed (Table 2) Administrative Rules Keyword Search Current Rules Rules by Topic (Index) Rules Archive Minnesota Rule Status State Register Other Legal Materials Minnesota Constitution State Constitutional Amendments Court Rules
- Multimedia Multimedia - Audio, Video, Broadcast TV, News, & Photos House Live Video Audio Webcast Schedule Audio & Video Archives Session Daily Photos Senate Live Video Audio Webcast Schedule Audio & Video Archives Senate Media Services Photos Joint Combined Media Page Legislative Media Archive Broadcast TV Schedule Commission Audio/Video
- Publications Legislative Research, Reports & Information Office Research & Reports House Fiscal Analysis House Research Senate Counsel Publications Legislative Auditor Revisor Publications Legislative Reference Library News House Session Daily Senate Media Services Senate Information Legislators Roster Member Guide Legislative History Legislative History Guide Legislators Past & Present House Journal Senate Journal Legislative Time Capsule Vetoes Notable Documents Fiscal Review Minnesota Issues Guides New Laws Books & reports
Office of the Revisor of Statutes
Revisor Menu- Retrieve by number Document type Statutes Laws Rules Bills GO
- Statutes
- Laws
- Rules
- Court Rules
- Constitution
- Revisor's Office Revisor Intranet Attorney Drafting Areas Staff Directory Office Duties Publications Educational Seminars Employment Openings Order Publications
- Search Law by Keyword
- Bills
- 94th Legislature (2025 - 2026)
- HF1076
- Introduction
HF 1076
Introduction - 94th Legislature (2025 - 2026)
Posted on 04/02/2025 12:30 p.m.
KEY:Bill Text Versions
| Engrossments | ||
|---|---|---|
| Introduction PDF | Posted on 02/17/2025 |
1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31
3.32
A bill for an act
relating to health; requiring pharmacy benefit managers and health carriers to
include lower-cost drugs in their formularies; requiring formulary structure and
formulary tiering for each health plan to give preference to the drug with the lowest
out-of-pocket cost to the patient; proposing coding for new law in Minnesota
Statutes, chapter 62W.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
new text begin
[62W.16] INCLUSION OF LOWER-COST DRUGS IN FORMULARY.
new text end
new text begin Subdivision 1. new text end
new text begin Definitions. new text end
new text begin
(a) For purposes of this section, the following definitions
apply.
new text end
new text begin
(b) "Biologic" has the meaning provided in section 62J.86, subdivision 3.
new text end
new text begin
(c) "Biosimilar" has the meaning provided in section 62J.84, subdivision 2, paragraph
(b).
new text end
new text begin
(d) "Brand name drug" has the meaning provided in section 62J.84, subdivision 2,
paragraph (c).
new text end
new text begin
(e) "Equivalent" means:
new text end
new text begin
(1) with respect to a generic drug, the brand name drug against which the generic drug
is evaluated by the United States Food and Drug Administration under United States Code,
title 21, section 355(j); and
new text end
new text begin
(2) with respect to a biosimilar, the brand name drug biological product as defined in
United States Code, title 42, section 262(i).
new text end
new text begin
(f) "Generic drug" has the meaning provided in section 62J.84, subdivision 2, paragraph
(e).
new text end
new text begin
(g) "Health plan" means a policy, contract, certificate, or agreement defined in section
62A.011, subdivision 3.
new text end
new text begin
(h) "Out-of-pocket cost" means any coinsurance, co-payment, or other form of
cost-sharing for which a patient is responsible.
new text end
new text begin
(i) "Wholesale acquisition cost" has the meaning provided in section 62J.86, subdivision
11.
new text end
new text begin Subd. 2. new text end
new text begin
Brand name, generic, and biosimilar drugs; inclusion of lowest-cost drug
in formulary.
new text end
new text begin
(a) If a pharmacy benefit manager or health carrier includes in its formulary
a brand name drug, it must also include in its formulary, if applicable, the equivalent generic
drug that has a wholesale acquisition cost that is lower than:
new text end
new text begin
(1) the wholesale acquisition cost of the brand name drug; and
new text end
new text begin
(2) the wholesale acquisition cost of any other equivalent generic drug.
new text end
new text begin
(b) If a pharmacy benefit manager or health carrier includes in its formulary a generic
drug, it must also include in its formulary, if applicable, the brand name drug to which the
generic drug is equivalent, if the brand name drug has a wholesale acquisition cost that is
lower than:
new text end
new text begin
(1) the wholesale acquisition cost of the generic drug included in the formulary; and
new text end
new text begin
(2) the wholesale acquisition cost of any other equivalent generic drug.
new text end
new text begin
(c) If a pharmacy benefit manager or health carrier includes in its formulary a brand
name biologic, it must also include in its formulary, if applicable, the equivalent biosimilar
that has a wholesale acquisition cost that is lower than:
new text end
new text begin
(1) the wholesale acquisition cost of the brand name biologic; and
new text end
new text begin
(2) the wholesale acquisition cost of any other equivalent biosimilar.
new text end
new text begin
(d) If a pharmacy benefit manager or health carrier includes in its formulary a biosimilar,
it must also include in its formulary, if applicable, the brand name biologic to which the
biosimilar is equivalent, if the brand name biologic has a wholesale acquisition cost that is
lower than:
new text end
new text begin
(1) the wholesale acquisition cost of the biosimilar included in the formulary; and
new text end
new text begin
(2) the wholesale acquisition cost of any other equivalent biosimilar.
new text end
new text begin Subd. 3. new text end
new text begin
New generic and biosimilar drugs; inclusion of lowest-cost drug in
formulary.
new text end
new text begin
(a) If a generic drug is approved by the United States Food and Drug
Administration, is marketed pursuant to that approval, and has a wholesale acquisition cost
that is less than the brand name drug or generic drug with the lowest wholesale acquisition
cost already included in the formulary of a pharmacy benefit manager or health carrier, the
pharmacy benefit manager or health carrier must immediately make the newly approved
generic drug available on its formulary.
new text end
new text begin
(b) If a biosimilar is approved by the United States Food and Drug Administration, is
marketed pursuant to that approval, and has a wholesale acquisition cost that is less than
the brand name biologic or biosimilar with the lowest wholesale acquisition cost already
included in the formulary of a pharmacy benefit manager or health carrier, the pharmacy
benefit manager or health carrier must immediately make the newly approved biosimilar
available on its formulary.
new text end
new text begin Subd. 4. new text end
new text begin Formulary structure and tiering. new text end
new text begin
(a) A pharmacy benefit manager or health
carrier must structure its formulary and any formulary tiers for each health plan in a manner
that gives preference to the brand name drug or the equivalent generic drug that has the
lowest out-of-pocket cost to the patient purchasing the drug product. The pharmacy benefit
manager or health carrier must not impose any prior authorization or step therapy requirement
or other limitation on coverage of the drug product with the lowest out-of-pocket cost to
the patient under the patient's health plan, or impose a restriction on a pharmacy that makes
it more difficult for the patient under the patient's health plan to obtain coverage of or access
to the drug product with the lowest out-of-pocket cost to the patient.
new text end
new text begin
(b) A pharmacy benefit manager or health carrier must structure its formulary and any
formulary tiers for each health plan in a manner that gives preference to the brand name
biologic or the equivalent biosimilar that has the lowest out-of-pocket cost to the patient
purchasing the drug product. The pharmacy benefit manager or health carrier must not
impose any prior authorization or step therapy requirement or other limitation on coverage
of the drug product with the lowest out-of-pocket cost to the patient under the patient's
health plan, or impose a restriction on a pharmacy that makes it more difficult for the patient
under the patient's health plan to obtain coverage of or access to the drug product with the
lowest out-of-pocket cost to the patient.
new text end
new text begin EFFECTIVE DATE. new text end
new text begin
This section is effective January 1, 2026.
new text end
- Historical Information
- Employment/Internships
- Visiting the Capitol
- Accessibility
- Frequently Asked Questions
- Who Represents Me?
- House Members
- Senators
- Contact a legislative librarian:
- (651) 296-8338 or Email
- Phone Numbers
- Submit website comments
- House News
- Senate News
- MyBills
- Email Updates & RSS Feeds
Texto oficial de la Legislatura de Minnesota. El formato se adaptó para leerlo en Ratifi.